Ares Financial Consulting’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5
Closed -$533 – 1101
2026
Q2
$533 Buy
+5
New +$605 ﹤0.01% 1083

Other funds holding INSM

Ares Financial Consulting's INSM Position: Q3 2026 in Review

Ares Financial Consulting sold out of Insmed (INSM) in Q3 2026, closing a stake of 5 shares — an estimated $533 sold.

Ares Financial Consulting first reported a position in INSM in Q2 2026 and held it in 1 quarter. The position peaked at $533 in Q2 2026. 562 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Ares Financial Consulting reported no remaining Insmed position as of Q3 2026 after selling out during the quarter.
  • Ares Financial Consulting sold 5 Insmed shares in Q3 2026, an estimated $533.
  • Ares Financial Consulting first reported a position in Insmed in Q2 2026 and held it in 1 quarter.
  • Ares Financial Consulting's Insmed position peaked at $533 in Q2 2026.
  • 562 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.